Cosmeceutical peptides

  1. Mary P Lupo1,
  2. Anna L Cole2

Article first published online: 28 NOV 2007

DOI: 10.1111/j.1529-8019.2007.00148.x

Issue

Dermatologic Therapy

Dermatologic Therapy

Volume 20, Issue 5, pages 343–349, September 2007

Additional Information

How to Cite

Lupo, M. P. and Cole, A. L. (2007), Cosmeceutical peptides. Dermatologic Therapy, 20: 343–349. doi: 10.1111/j.1529-8019.2007.00148.x

Author Information

  1. 1

    Lupo Center for Aesthetic and General Dermatology, New Orleans, Louisiana and

  2. 2

    Tulane Department of Dermatology, New Orleans, Louisiana

*Address correspondence and reprint requests to: Mary P. Lupo, MD, 145 Robert E. Lee Blvd, Suite 302, New Orleans, Louisiana 70124, or email: DrLupo@DrMaryLupo.com.

Publication History

  1. Issue published online: 28 NOV 2007
  2. Article first published online: 28 NOV 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (2123K)

Keywords:

  • carrier peptide;
  • cosmeceutical;
  • neurotransmitter-affecting peptide;
  • peptide;
  • signal peptide

ABSTRACT:  Peptide cosmeceuticals are one of the new, popular options to treat aging skin. There are three main categories of cosmeceutical peptides: signal peptides, neurotransmitter-affecting peptides and carrier peptides. Although their benefits currently may not be as rigorously tested as most FDA-regulated drugs, the evidence to support their use is growing. This article attempts to review the various current popular cosmeceutical peptides, the published studies on their theoretical effects, and their practical use in dermatology.

View Full Article (HTML) Get PDF (2123K)